• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6-巯基嘌呤在肾脏中的靶向作用。大鼠体内S-(6-嘌呤基)-L-半胱氨酸类似物的代谢及肾脏选择性

Targeting of 6-mercaptopurine to the kidneys. Metabolism and kidney-selectivity of S-(6-purinyl)-L-cysteine analogs in rats.

作者信息

Elfarra A A, Hwang I Y

机构信息

Department of Comparative Biosciences, University of Wisconsin-Madison.

出版信息

Drug Metab Dispos. 1993 Sep-Oct;21(5):841-5.

PMID:7902246
Abstract

Previously, we have shown that 30 min after S-(6-purinyl)-L-cysteine (PC; 0.13 or 0.4 mmol/kg, ip) treatment of rats, kidney concentrations of 6-mercaptopurine (6-MP) and its further metabolites, 6-methylmercaptopurine and 6-thiouric acid, were nearly 2.4-fold higher than those in liver, and were nearly 90-fold higher than those in plasma. 6-MP was also detected in the urine of rats given the PC analogs, S-(6-purinyl)-N-acetyl-L-cysteine (NAPC), S-(6-purinyl)glutathione (PG), and S-(6-purinyl)-L-homocysteine (PHC). In this study, the kidney-selectivity of the PC analogs was investigated by determining the concentrations of 6-MP and its further metabolites in the kidney, liver, and plasma of rats given the analogs. After NAPC, PG, and PHC (0.8 mmol/kg, ip) treatments, kidney concentrations of total metabolites at 30 min were nearly 17.6-, 6.5-, and 2.9-fold higher than those in liver, respectively. Only trace amounts of metabolites were detected in plasma with any analog. After NAPC treatment (0.8 mmol/kg, ip) total metabolite concentrations in the kidney at 30 min were higher than those detected at 60 or 90 min. When the PC analogs were given at a lower dose (0.4 mmol/kg), only trace amounts of metabolites were detected in the kidney, and no metabolites were detected in liver or plasma. Rates of in vitro metabolism of PHC, PG, and NAPC to 6-MP by kidney homogenates were nearly 10.0, 6.7, and 0.3% of that measured with PC, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

此前,我们已表明,给大鼠腹腔注射S-(6-嘌呤基)-L-半胱氨酸(PC;0.13或0.4 mmol/kg)30分钟后,肾脏中6-巯基嘌呤(6-MP)及其进一步代谢产物6-甲基巯基嘌呤和6-硫尿酸的浓度比肝脏中的浓度高近2.4倍,比血浆中的浓度高近90倍。在给予PC类似物S-(6-嘌呤基)-N-乙酰-L-半胱氨酸(NAPC)、S-(6-嘌呤基)谷胱甘肽(PG)和S-(6-嘌呤基)-L-高半胱氨酸(PHC)的大鼠尿液中也检测到了6-MP。在本研究中,通过测定给予类似物的大鼠肾脏、肝脏和血浆中6-MP及其进一步代谢产物的浓度,研究了PC类似物的肾脏选择性。给予NAPC、PG和PHC(0.8 mmol/kg,腹腔注射)后,30分钟时肾脏中总代谢产物的浓度分别比肝脏中的浓度高近17.6倍、6.5倍和2.9倍。用任何一种类似物处理后,血浆中仅检测到微量代谢产物。给予NAPC(0.8 mmol/kg,腹腔注射)后,30分钟时肾脏中总代谢产物浓度高于60或90分钟时检测到的浓度。当以较低剂量(0.4 mmol/kg)给予PC类似物时,肾脏中仅检测到微量代谢产物,肝脏和血浆中未检测到代谢产物。肾脏匀浆将PHC、PG和NAPC体外代谢为6-MP的速率分别约为PC测定值的10.0%、6.7%和0.3%。(摘要截短于250字)

相似文献

1
Targeting of 6-mercaptopurine to the kidneys. Metabolism and kidney-selectivity of S-(6-purinyl)-L-cysteine analogs in rats.6-巯基嘌呤在肾脏中的靶向作用。大鼠体内S-(6-嘌呤基)-L-半胱氨酸类似物的代谢及肾脏选择性
Drug Metab Dispos. 1993 Sep-Oct;21(5):841-5.
2
Kidney-selective prodrugs of 6-mercaptopurine: biochemical basis of the kidney selectivity of S-(6-purinyl)-L-cysteine and metabolism of new analogs in rats.6-巯基嘌呤的肾选择性前药:S-(6-嘌呤基)-L-半胱氨酸肾选择性的生化基础及大鼠体内新类似物的代谢
J Pharmacol Exp Ther. 1991 Jul 1;258(1):171-7.
3
Detection and mechanisms of formation of S-(6-purinyl)glutathione and 6-mercaptopurine in rats given 6-chloropurine.给予6-氯嘌呤的大鼠体内S-(6-嘌呤基)谷胱甘肽和6-巯基嘌呤的检测及形成机制
J Pharmacol Exp Ther. 1993 Jan;264(1):41-6.
4
Cysteine S-conjugates may act as kidney-selective prodrugs: formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine.半胱氨酸S-共轭物可能作为肾脏选择性前体药物:S-(6-嘌呤基)-L-半胱氨酸经肾脏代谢生成6-巯基嘌呤。
J Pharmacol Exp Ther. 1989 Nov;251(2):448-54.
5
Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats.
J Pharmacol Exp Ther. 1999 Sep;290(3):950-7.
6
Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine.
J Pharmacol Exp Ther. 1995 Sep;274(3):1298-304.
7
In vivo metabolites of S-(2-benzothiazolyl)-L-cysteine as markers of in vivo cysteine conjugate beta-lyase and thiol glucuronosyl transferase activities.
Drug Metab Dispos. 1990 Nov-Dec;18(6):917-22.
8
N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine and 2,2,2-trichloroethanol: two novel metabolites of tetrachloroethene in humans after occupational exposure.N-乙酰-S-(1,2,2-三氯乙烯基)-L-半胱氨酸和2,2,2-三氯乙醇:职业暴露后人体中四氯乙烯的两种新型代谢产物。
Drug Metab Dispos. 1996 Jan;24(1):41-8.
9
Effect of oral and intravenous S,N-diacetylcysteine monoethyl ester on circulating and hepatic sulfhydryls in the Rat.口服和静脉注射S,N-二乙酰半胱氨酸单乙酯对大鼠循环和肝脏巯基的影响。
J Pharmacol Exp Ther. 2000 Jul;294(1):155-9.
10
Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation.全氯乙烯的生物转化:大鼠和人类吸入后三氯乙酸、二氯乙酸和N-乙酰-S-(三氯乙烯基)-L-半胱氨酸的剂量依赖性排泄
Toxicol Appl Pharmacol. 1998 Nov;153(1):20-7. doi: 10.1006/taap.1998.8548.

引用本文的文献

1
Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design.基于毒性机制的前药:谷胱甘肽依赖性生物活化作为抗癌前药设计的策略。
Expert Opin Drug Discov. 2018 Sep;13(9):815-824. doi: 10.1080/17460441.2018.1508207. Epub 2018 Aug 13.
2
Glutathione Transferase (GST)-Activated Prodrugs.谷胱甘肽转移酶(GST)激活前药。
Pharmaceutics. 2013 Apr 2;5(2):220-31. doi: 10.3390/pharmaceutics5020220.
3
Cysteine S-conjugate β-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents.
半胱氨酸 S-结合物β-裂合酶:在天然含硫和硒化合物、外源性化合物和抗癌剂的代谢中的重要作用。
Amino Acids. 2011 Jun;41(1):7-27. doi: 10.1007/s00726-010-0552-0. Epub 2010 Mar 22.